ADAR1 Capital Management, LLC - Significant Ownership

Signature - Title
/s/ Daniel Schneeberger - Daniel Schneeberger, Manager
Location
Austin, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ADAR1 Capital Management, LLC.

Significant Ownership of ADAR1 Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KROS Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share 13.27% $78M -$24.6K 5.39M -0.03% ADAR1 Capital Management, LLC Aug 21, 2025
ACST Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% 1.5M ADAR1 Capital Management GP, LLC Mar 31, 2025
IKT Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value 9.9% $13M $1.25M 7.74M +10.6% ADAR1 Capital Management GP, LLC Jun 30, 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.9% $1.42M $551K 1.79M +63.7% ADAR1 Capital Management, LLC Jun 30, 2025
KPRX Kiora Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 9.9% $1.03M 365K ADAR1 Capital Management GP, LLC Jun 30, 2025
PRTA Prothena Corporation Public Limited Company Ordinary Shares, par value $0.01 per share 6.3% $27.8M 3.38M ADAR1 Capital Management, LLC Jun 30, 2025
BIOA BioAge Labs, Inc. Common Stock, par value $0.00001 per share 5.4% $9.3M 1.94M ADAR1 Capital Management, LLC Jun 30, 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 4.91% $1.01M 299K ADAR1 Capital Management, LLC Dec 31, 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 3.18% $2.33M 2.08M ADAR1 Capital Management, LLC Dec 31, 2024
CLRB Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share 0.1% 2.96K ADAR1 Capital Management, LLC Jun 30, 2025

Schedules 13D/G Reported by ADAR1 Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.